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Introduction
Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with significant mortality, primarily through stroke and heart failure (2, 3) . There are many causes of AF and although patients generally show multiple predisposing risk factors, >70% of patients have some form of underlying structural heart disease (2, 3) . Evidence from animal models of heart diseases that predispose to AF indicates that disease-associated remodeling of the atria, presumably due to mechanical overload of the atrial wall, creates an arrhythmic substrate in which AF is more likely to arise and be sustained (10, 13, 22, 29, 30, 32, 34, 48) . In addition to atrial enlargement, fibrosis and conduction abnormalities that establish a substrate for re-entry, cellular remodeling involving cellular hypertrophy, changes in membrane structure and abnormal expression and function of ion channels and transporters are also likely to contribute to the genesis of AF (4, 10, 13, 15, 16, 18, 22, 26, 29, 30, 32, 34, 35, 38, 48, 51) .
Atrial L-type Ca 2+ current (ICaL) is reduced in heart disease, both in animal models (4, 13, 29, 38) and in myocytes from human dilated atria (19, 33) . The loss of ICaL has been suggested to have a number of sequelae that contribute to the genesis of AF, including (i) changes in action potential configuration and the rate-dependence of refractoriness, (ii) abnormalities in Ca 2+ handling and the triggering of episodes of AF and (iii) hypo-contractility and dilatation of the atria (15, 29, 33, 35, 42) . The mechanisms for the downregulation of ICaL remain unclear and may be dependent on the underlying disease. For example, both spontaneously hypertensive rats and rats with coronary artery ligation-induced myocardial infarction show a substrate for atrial fibrillation associated with atrial fibrosis, hypertrophy and down-regulation in ICaL (4, 10, 13, 38) . However, while the reduced ICaL density in atrial myocytes from spontaneously hypertensive rats compared to currents in normotensive Wistar-Kyoto controls has been associated with reduction in expression of the pore-forming 1c subunit, 1c protein expression was unchanged in rat atrial myocytes from a coronary artery ligation model (4, 38) . The reduction in atrial ICaL in coronary artery ligation-induced heart failure has been suggested to be due to decreased cyclic AMP-dependent basal regulation of L-type Ca 2+ channels (4, 19) . However, while the cyclic AMP-dependent protein kinase, PKA, has also been demonstrated to play an important role in the basal regulation of ICaL in ventricular myocytes (7, 8) , the constitutive regulation of ventricular ICaL by PKA appears to be increased in a coronary artery ligation model of heart failure (9) . In addition, the reduction in atrial ICaL in patients with chronic AF has been associated with a reduction in calcium-calmodulin-dependent protein kinase II (CaMKII) activity and an increase in protein phosphatase activity in AF with no change in the expression of L-type Ca 2+ channel subunit protein (14) . Changes in the activity of the serine/threonine protein phosphatases, PP1 and PP2A, and the regulatory subunit of PP1, inhibitor-1, have been implicated in the proarrhythmic remodeling in AF (25) . Thus, the aim of this study was to examine the mechanisms underlying the regulation of atrial ICaL in heart failure. The study involved the use of the coronary artery ligation model of myocardial infarction-associated heart failure reported previously (9, 23).
Materials & Methods
Animals, heart failure and myocyte isolation. All procedures were performed in accordance with UK legislation and approved by the University of Bristol Ethics Committee. The study was conducted in parallel with another investigation using the same animals to investigate ventricular cellular remodeling in heart failure and thereby conformed to the reduction component of the 3Rs (9, 23, 41) . Heart failure was induced in 10 adult male Wistar rats by ligation of the left anterior descending coronary artery (CAL), which results in left ventricular hypertrophy and dilatation, and systolic and diastolic dysfunction 16 weeks after surgery (9, 36) . 12 adult male Wistar rats were subject to an equivalent Sham operation (Sham). Left atrial myocytes were isolated ~18 weeks after surgery. Operations were performed under surgical anesthesia (ketamine 75 mg/kg, medetomidine 0.5 mg/kg, ip) with appropriate analgesia (buprenorphine 0.05 mg/kg, sc). We have previously reported that left ventricular ejection fraction was reduced by 50% and left ventricular end diastolic volume was increased by more than 100% in CAL as compared with Sham for this group of animals (9) .
Atrial myocytes were isolated using our standard methods (6, 8) , following rapid excision of the heart under pentobarbitone anesthesia. Isolated myocytes were stored for 2-10 hours before use on the day of isolation.
Whole-cell recording. Whole-cell currents were recorded using the ruptured-patch technique, as described previously (6) . Myocytes were superfused with Tyrode's solution Whole-cell capacitance transients were compensated electronically. Series resistances were typically between 3 -8 MΩ in both Sham and CAL myocytes and were not compensated and no corrections were made for voltage-drop error. A square-shaped voltage pulse protocol was applied: from a holding potential of -80 mV, 500 ms depolarizing pulses to potentials from -40 mV to +50 mV were applied, increasing in 10 mV increments every 5 s. A 50 ms pre-pulse to -40 mV was used to inactivate the Na + current. The L-type Ca 2+ current (ICaL) was measured as the difference between the peak inward current and the current at the 
where Vm was the membrane potential, Gmax represented the maximum conductance, Vrev was the effective reversal potential for the current, Vhalf represents the voltage of halfmaximal activation and k represented a slope factor (6) . Fitted parameters are reported with the standard error of fitting.
Drugs and reagents. All reagents were purchased from Sigma-Aldrich (Poole, UK) unless otherwise indicated. Norepinephrine (NE) was dissolved in de-ionized water as a 10 mmol/L stock-solution and dissolved to the final concentration in the extracellular solution on the day of experiment. 1 μmol/L of NE was used as an effective concentration of the physiological agonist of adrenoceptors previously shown to potentiate ICaL maximally and that is representative of concentrations achieved at the cardiac sympathetic junction (6, 24) .
Protein kinase A (PKA) was inhibited using 10 μmol/L H-89, a concentration that has been shown to inhibit phosphorylation of the cardiac 1c L-type Ca 2+ channel subunit (12). In some experiments, autocamtide-2-related inhibitory peptide (AIP) was included in the pipette solution (5 μmol/L) to inhibit Ca 2+ -calmodulin-dependent kinase II (CaMKII) (27) .
Calyculin A (Cal A) was used at a concentration of 100 nmol/L to inhibit the serine/threonine protein phosphatases 1 (PP1) and 2A (PP2A) (39) .
Western blotting. 30 μg of protein from cell homogenate samples was run on reducing 4-15% gradient SDS-PAGE gels and transferred to Immobilon-P membranes. Membranes were probed with anti-Cav1.2 L-type Ca 2+ channel 1c subunit (ACC-003; Alomone, Israel), antiprotein phosphatase 1 (anti-PP1, sc-7482; Santa Cruz Biotechnology Inc., Texas, USA), antiprotein phosphatase 2A (anti-PP2A, 05-421; Millipore (UK) Ltd, Watford, UK) and antiprotein phosphatase inhibitor-1 (anti-Inhibitor-1, ab-40877; AbCam, Cambridge, UK).
Protein bands were visualized and images captured using the appropriate horseradish peroxidase-conjugated secondary antibodies, chemiluminescence and a G:BOX Chemi XT4
imaging system (Syngene). The densities of the bands were measured using ImageJ Bonferroni's multiple-comparisons test. P≤0.05 was considered as the limit of statistical confidence.
Results
Single left atrial myocytes were isolated from Sham and CAL rats 18.9±0.45 weeks (n=12) and 18.7±0.48 weeks (n=10, P=0.678) following surgery, respectively. On the day of isolation, there was little difference between the two groups in body weight (Sham, 447.3±9.04 g vs CAL, 491.5±20.1 g; P=0.052) or tibia length (Fig. 1A) . However, CAL animals showed significantly increased heart weights (HW) and lung weights (LW) relative to tibia length (TL; Fig. 1B ), indicative of early stage heart failure as demonstrated in our previous report using these hearts (9) . In summary, the data indicate early onset heart failure in the CAL animals in the present study. Whole-cell capacitance values of left atrial myocytes isolated from CAL hearts were ~1.67 times larger than those from Sham controls, indicating considerable cellular hypertrophy of atrial myocytes in heart failure ( Fig. 2A) . Cell length and width were measured in 12 Sham (from 2 hearts) and 12 CAL (from 2 hearts) isolated atrial Figure 2E . In CAL cells, ICaL density was inversely correlated with capacitance (r=-0.4219, n=31, P=0.0181). Taken together, these data indicate that heart failure through coronary artery ligation causes a reduction in whole-cell ICaL density of left atrial myocytes that is predominantly due to an increase in cell membrane surface area with minor changes in absolute current.
The reduction in atrial ICaL density by more than 50% caused by CAL-induced heart failure was consistent with a previous report in a similar model, in which it was also shown that the difference in ICaL density between sham control and heart failure was reduced following βadrenoceptor stimulation with isoproterenol (4). The sympathetic neurotransmitter, NE, has previously been shown to potentiate atrial ICaL via β1-adrenoceptors without significant contribution from either α1-or β2-adrenoceptors (6) . Therefore, the effects of NE on differences in ICaL density between Sham and CAL atrial myocytes were examined. As illustrated by the representative current traces in Figure 3 , 1 μmol/L NE produced a marked increase in ICaL in both Sham and CAL myocytes ( Fig. 3A & Fig. 3B ). Notably, although statistically significant differences in ICaL density-voltage relations (Fig. 3C) Overall, these data demonstrate differences in the regulation of the L-type Ca 2+ channel currents between Sham and CAL cells. To examine whether constitutive phosphorylation of LTCC contributed to the differences in ICaL density, cells were superfused with the serine/threonine protein phosphatase inhibitor, calyculin A (100 nmol/L) ( Fig. 4) . In both groups of cells, calyculin A resulted in increased mean current densities at voltages from -20 mV to +40 mV ( Fig. 4) . However, the relative increase in maximal conductance was not significantly different between the two groups (P=0. The role of protein kinase A in differences in basal ICaL density between the two groups of atrial cells was examined using the PKA inhibitor, H-89 (10 μmol/L) ( Fig. 5 ). Superfusion of cells with H-89 had no effect on basal ICaL in either Sham (Fig. 5A) or CAL (Fig. 5B) ICaL density at +10 mV in Sham cells (data not shown). Taken together, these data suggest that inhibition of CaMKII had no effect on basal ICaL in either Sham or CAL myocytes.
The expression of proteins for the predominant LTCC pore-forming α1c subunit, Cav1.2, for the serine/threonine protein phosphatases, PP1 and PP2A, and for the inhibitory subunit of PP1, inhibitor-1, was examined by Western blotting in atrial cell preparations from 3 Sham and 3 CAL hearts (Figure 7 ). There were no significant differences in the total content of 1c subunit relative to GAPDH expression between the two groups of cells. The increase in ICaL density on inhibition of protein phosphatase with calyculin A (Fig. 4) indicates a role for protein phosphorylation in the basal regulation of L-type Ca 2+ channels in both groups of cells. However, expression of neither PP1 nor PP2A were changed in heart failure (Fig. 7) .
Moreover, the PKA-dependent inhibitory regulator of PP1, inhibitor-1, reduced expression of which in failing ventricles has been suggested to contribute to reduced protein phosphorylation (20) , was also not different between the two groups of cells.
Discussion
This study clearly demonstrates a reduction in atrial ICaL density in heart failure, due predominantly to cellular hypertrophy without significant change in absolute current amplitude. However, the total expression of the 1c subunit protein relative to total tissue protein was also not changed in heart failure, indicating that the reduction in basal current density in heart failure did not involve significant changes in the relative amount of protein in hypertrophied cells. It seems likely that a change in L-type Ca 2+ channel regulation underlay the reduction in ICaL density. The difference in ICaL density between atrial cells from failing and sham hearts was abolished in the presence of NE, which increased the L-type Ca 2+ current >50% more effectively in CAL cells than in Sham. Moreover, the increase in current density produced by inhibition of serine/threonine protein phosphatase activity with calyculin A provides evidence of phosphorylation-dependent basal regulation of ICaL in both groups of cells. In these respects, the data resemble those reported by Dinanian et al in human atrial myocytes from patients with heart failure (19) and by Boixel et al in a model of coronary artery ligation-induced heart failure in rats similar to that used in the present study (4) and contrast with studies of chronic hypertension and pressure overload in rats that show a reduction in atrial 1c subunit protein expression (38, 51) . However, contrary Basal ICaL in the present study was also insensitive to AIP and KN-93, demonstrating that, unlike human atrial myocytes, CaMKII did not contribute to the constitutive regulation of the L-type Ca 2+ current (14).
The present study showed little difference between atrial cells from failing hearts and sham controls in the effectiveness of inhibition of the protein phosphatases PP1 and PP2A so that, in contrast to previous reports, differences in protein dephosphorylation via these phosphatases are unlikely to account for the downregulation of atrial ICaL density in heart failure (4, 14) . Consistent with this suggestion, no differences were found in the expression of PP1, PP2A or inhibitor-1. The basis for the differences between the study of Boixel et al and the present study, in which similar models of heart failure were used, remain unclear although it is possible that the results of the present study, in which animals were maintained for 18 weeks following coronary artery ligation, represent a more chronic state of remodeling than did those of Boixel et al, in which animals were maintained for 3 months post-surgery (4, 9, 36, 37) .
The mechanism for the down regulation of atrial ICaL in heart failure remains unclear. A number of kinases, including PKC, PKD, PKG and tyrosine kinases, have been reported to modulate cardiac ICaL and, in principle, changes in the activity of any of these could contribute to the reduction in basal ICaL in heart failure (1, 5, 28) . Additionally, calcineurin (PP2B) has been suggested to associate with and regulate the L-type Ca 2+ channel α1csubunit and to contribute to down-regulation of ICaL during atrial remodeling (46, 53) . Atrial ICaL is also regulated by NO through complex pathways involving cyclic GMP-dependent PKG, cyclic GMP-inhibited phosphodiesterases, and S-nitrosylation of the α1c-subunit (31, 40, 47, 49) . It has been suggested that oxidative stress may contribute to the development of the arrhythmic substrate and down-regulation of ICaL during atrial remodeling and this may involve changes in the NO-dependent regulation of L-type Ca 2+ channels (11, 21, 43) . The previously reported changes in atrial intracellular cyclic GMP production together with the increased effect of phosphodiesterase inhibition on ICaL are consistent with the proposal that changes in NO/cGMP-dependent regulation of L-type Ca 2+ channels may underlie both the reduced basal current and increased sensitivity to noradrenergic agonism in heart failure (4, 19) . On the other hand, while it has previously been shown that the effect of NE on ICaL is almost exclusively mediated via β1-adrenoceptors in atrial myocytes from normal hearts (6) , the contribution of α1-, β2 and β3-adrenoceptors in heart failure cannot be ruled out (44, 45, 52) . Thus, future studies using selective adrenoceptor ligands and inhibitors of signaling cascades will be important to establish the mechanism underlying the remodeling of atrial ICaL regulation in heart failure.
The present study also adds to evidence that the mechanisms of ICaL regulation differ between atrial and ventricular cells (6) (7) (8) . While both PKA and CaMKII have previously been shown to contribute to the basal regulation of ventricular ICaL, particularly at the t-tubule membrane, (7) (8) (9) 12) , basal ICaL in atrial myocytes from either sham control or failing hearts in the present study was insensitive to inhibition of PKA or CaMKII. Notably, the absence of regulation of basal atrial ICaL by PKA in CAL hearts in the present study contrasts markedly with the increased PKA-dependent regulation of basal ICaL at the t-tubule of ventricular myocytes reported recently from the same hearts (9) . The action of calyculin A on atrial ICaL demonstrates both that the basal regulation of ICaL in rat atrial myocytes depends on constitutive phosphorylation by a serine/threonine kinase and that PP1/PP2A phosphatase activity contributes to the degree of basal phosphorylation. Thus, the identity of the kinases and phosphatases responsible for the constitutive regulation of atrial ICaL in both normal hearts and in heart failure warrants further investigation. 
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